Aims To quantify nationwide incidence and contemporary treatment patterns of acute retinal necrosis (ARN). Methods ...
Background To describe a technique for treating extraocular muscle adherence after failed fracture repair(s). Methods ...
Background/Aims To investigate the characteristics of fast-progressors among Asian patients with normal tension glaucoma (NTG ...
Purpose To evaluate anatomical, visual and cosmetic rehabilitation outcomes of symblepharon release with fornix reconstruction (SR-FR) in eyes with chronic chemical injury and identify factors ...
Purpose To establish normative axial length growth references for preterm infants without retinopathy of prematurity (ROP) and term-born children under 5 years and construct templates to aid ...
Prophylactic treatment of lattice degeneration with laser photocoagulation remains controversial. We evaluated whether prophylactic laser for lattice degeneration increases epiretinal membrane (ERM) ...
Background Postoperative microbial keratitis (MK) can cause graft failure and vision loss following keratoplasty for corneal endothelial decompensation. Many previous studies found penetrating ...
Purpose The cross-sectional and longitudinal associations between accelerated biological ageing and the risk of cataract and other blinding eye diseases (including glaucoma and age-related macular ...
Aims To compare 1-year and 2-year outcomes of eyes with persistent and non-persistent diabetic macular oedema (DME) treated with vascular endothelial growth factor (VEGF) inhibitors. Methods This was ...
Purpose Fundus fluorescein angiography (FFA) is an important tool in evaluating retinal vascular disease. In the era of optical coherence tomography angiography (OCTA), however, expert preferences ...
Purpose To evaluate the prognostic value of estimated tumour volume as a continuous biomarker in uveal melanoma and to compare its discriminative performance with the American Joint Committee on ...
Background/aims To evaluate real-world, short-term anatomical and functional outcomes of faricimab versus aflibercept 2 mg in diabetic macular oedema (DMO). Methods This retrospective, parallel-cohort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results